chr3-194604391-C-G
Variant summary
Our verdict is Likely benign. Variant got -2 ACMG points: 2P and 4B. PM2BP4_Strong
The NM_001011655.3(TMEM44):āc.1072G>Cā(p.Ala358Pro) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00049 in 1,547,870 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 15/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (ā ).
Frequency
Consequence
NM_001011655.3 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -2 ACMG points.
Transcripts
RefSeq
Ensembl
Frequencies
GnomAD3 genomes AF: 0.000256 AC: 39AN: 152248Hom.: 0 Cov.: 33
GnomAD3 exomes AF: 0.000296 AC: 46AN: 155472Hom.: 0 AF XY: 0.000267 AC XY: 22AN XY: 82286
GnomAD4 exome AF: 0.000515 AC: 719AN: 1395504Hom.: 0 Cov.: 33 AF XY: 0.000503 AC XY: 346AN XY: 687602
GnomAD4 genome AF: 0.000256 AC: 39AN: 152366Hom.: 0 Cov.: 33 AF XY: 0.000228 AC XY: 17AN XY: 74512
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Jul 27, 2024 | The c.1213G>C (p.A405P) alteration is located in exon 10 (coding exon 10) of the TMEM44 gene. This alteration results from a G to C substitution at nucleotide position 1213, causing the alanine (A) at amino acid position 405 to be replaced by a proline (P). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at